We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Masimo Corporation | NASDAQ:MASI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.19 | 0.99% | 121.80 | 121.60 | 121.79 | 121.955 | 119.50 | 120.70 | 232,028 | 16:55:08 |
From Nov 2023 to May 2024
By Ben Glickman
Masimo's baby-monitoring system Stork has received approval from the U.S. Food and Drug Administration for medical uses.
The system is cleared by the FDA for prescription use in healthy and sick babies up to 18 months old.
Stork allows parents to monitor babies' oxygen saturation, pulse rate and skin temperature. Users can receive alarms regarding these metrics and can share information with doctors remotely.
The Irvine, Calif.-based medical-device company said Monday that the system was available at retailers nationwide as a non-medical device and could now be used as a medical device with a prescription.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
December 18, 2023 13:13 ET (18:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Masimo Chart |
1 Month Masimo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
